폐기능 검사(PFT) 시스템 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of pulmonary function testing (PFT) system Market

The global pulmonary function testing (PFT) system market is projected to grow steadily over the forecast period due to the rising prevalence of chronic respiratory diseases and technological advancements in diagnostic devices. Pulmonary function testing systems are specialized devices used to perform various respiratory assessments, including spirometry, lung volumes, plethysmography, diffusion capacity, and nitrogen washout tests. These systems are critical in diagnosing and managing respiratory disorders such as asthma, COPD, and lung cancer.

Market Size & Forecast

The global pulmonary function testing system market was valued at USD 171.2 million in 2025, expected to grow to USD 178.68 million in 2026, and is projected to reach USD 261.38 million by 2034, with a CAGR of 4.87% from 2026 to 2034. North America dominated the market in 2025 with a 41.60% share, led by the U.S., where rising awareness about early diagnosis and continuous advancements in PFT systems drive market growth. The U.S. market alone is projected to reach USD 90.1 million by 2032, reflecting strong adoption of both complete and portable PFT systems.

Market Drivers

The growth of the PFT system market is primarily driven by:

• Increasing prevalence of respiratory diseases, such as COPD, asthma, and occupational lung disorders, particularly in developing regions. According to the Global Asthma Report 2022, approximately 35 million people in India suffer from asthma, highlighting the urgent need for early diagnosis and monitoring.
• Rising awareness of early diagnosis among healthcare providers and patients. PFT systems allow early detection of lung dysfunction in asymptomatic individuals, enabling timely treatment.
• Technological advancements including portable PFT systems, which are increasingly used in clinics and decentralized healthcare facilities.

COVID-19 Impact

The COVID-19 pandemic temporarily hindered the market due to limited access to healthcare facilities and concerns about virus transmission during testing. According to the Canadian Thoracic Society (CTS), pulmonary function tests resumed only for patients with negative COVID-19 status. Post-pandemic, market recovery began in 2022, with demand steadily increasing as normal operations resumed.

Market Restraints

Despite growth, the market faces challenges, including:

• Risk of cross-contamination, as PFT procedures involve mouthpieces, valves, and tubing, which can transmit infections like tuberculosis.
• Shortage of skilled healthcare professionals, especially in developing countries. For instance, in India, the trained healthcare workforce falls below the recommended 22.8 skilled workers per 10,000 population, limiting effective adoption.

Market Segmentation

By Type:

• Complete systems dominated the market in 2026, reaching USD 105.47 million with a 59.03% share, driven by hospital adoption for comprehensive respiratory assessments.
• Portable systems are expected to exhibit the fastest growth due to increased use in clinics, independent diagnostic centers, and rising air pollution concerns.

By End-User:

• Hospitals held the largest share in 2026 at USD 95.32 million (53.35%), fueled by the growing geriatric population and increased patient visits for asthma and COPD.
• Physician clinics are projected to grow at the highest CAGR, supported by the adoption of portable systems.
• Physical examination/diagnostic centers also play a crucial role due to increased awareness of lung health and early diagnosis initiatives.

Regional Insights

• North America led the market with a valuation of USD 71.17 million in 2025, driven by high adoption of PFT systems and a growing prevalence of respiratory diseases. The U.S. market is projected at USD 68.5 million by 2026.
• Europe benefits from improved healthcare infrastructure and rising cases of COPD and asthma, with the UK at USD 7 million and Germany at USD 11.2 million by 2026.
• Asia Pacific is expected to witness the highest CAGR, propelled by awareness campaigns and healthcare infrastructure improvements. The Japan market is projected at USD 11.5 million, China at USD 14.5 million, and India at USD 5 million by 2026.
• Latin America and Middle East & Africa are growing steadily due to investments in healthcare infrastructure and rising demand for lung function testing.

Competitive Landscape

The market is consolidated with major players such as VYAIRE MEDICAL, INC., MGC Diagnostics Corporation, PulmOne Advanced Medical Devices, ndd Medizintechnik AG, KoKo PFT, and CHEST M.I., Inc.. Companies are focusing on product launches, partnerships, and geographic expansion. Key developments include:

• March 2023: Vitalograph launched the VitaloPFT Pulmonary Function Testing Series and partnered with Morgan Scientific to integrate advanced software with hardware.
• January 2023: CAIRE Inc. acquired MGC Diagnostics Corporation to strengthen its pulmonary disease expertise.

Market Trends

• Shift from complete to portable systems in clinics and decentralized healthcare settings.
• Rising adoption of PFT systems for early diagnosis and preventive care.
• Increasing investments by healthcare providers in technologically advanced diagnostic systems.

Conclusion

The global pulmonary function testing system market is projected to grow from USD 171.2 million in 2025 to USD 261.38 million by 2034, driven by increasing prevalence of chronic respiratory diseases, advancements in portable and complete systems, and rising awareness of early diagnosis. North America dominates the market, while Asia Pacific is emerging as the fastest-growing region. The market presents opportunities for key players through innovation, expansion into developing countries, and partnerships with healthcare providers.

Segmentation By Type

• Portable
• Complete

By End-user

• Hospitals
• Physical Examination (Diagnostic) Centers
• Physician Groups (Clinics)
• Others

By Region

• North America (By Type, By End-user, By Country)
  • U.S.
  • Canada
• Europe (By Type, By End-user, By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (By Type, By End-user, By Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, By End-user, By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By End-user, By Country/Sub-region)
  • South Africa
  • GCC
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Key Industry Developments (Mergers, Acquisitions, Partnerships)
• 4.2. Incidence and Prevalence of Asthma and COPD, Key Countries/ Region, 2025
• 4.3. Pricing, Key Products / Key Players, 2025
• 4.4. Impact of COVID-19 on the Market

5. Global Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Portable
  • 5.1.2. Complete
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals
  • 5.2.2. Physical Examination (Diagnostic) Centers
  • 5.2.3. Physician Groups (Clinics)
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Portable
  • 6.1.2. Complete
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals
  • 6.2.2. Physical Examination (Diagnostic) Centers
  • 6.2.3. Physician Groups (Clinics)
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Portable
  • 7.1.2. Complete
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals
  • 7.2.2. Physical Examination (Diagnostic) Centers
  • 7.2.3. Physician Groups (Clinics)
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Spain
  • 7.3.5. Italy
  • 7.3.6. Rest of Europe

8. Asia Pacific Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Portable
  • 8.1.2. Complete
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals
  • 8.2.2. Physical Examination (Diagnostic) Centers
  • 8.2.3. Physician Groups (Clinics)
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific

9. Latin America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Portable
  • 9.1.2. Complete
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals
  • 9.2.2. Physical Examination (Diagnostic) Centers
  • 9.2.3. Physician Groups (Clinics)
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America

10. Middle East & Africa Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Portable
  • 10.1.2. Complete
• 10.2. Market Analysis, Insights and Forecast - By End-user
  • 10.2.1. Hospitals
  • 10.2.2. Physical Examination (Diagnostic) Centers
  • 10.2.3. Physician Groups (Clinics)
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.3.1. South Africa
  • 10.3.2. GCC
  • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. ndd Medizintechnik AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. COSMED srl
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. MGC Diagnostics Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Morgan Scientific
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. CHEST M.I., Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. VYAIRE MEDICAL, INC.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. KoKo PFT
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Medical Electronic Construction
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)